SALT LAKE CITY, UT--(Marketwired - Nov 4, 2015) - NNRX USA, Inc. (OTC PINK: NNRX), a/k/a Nutranomics, Inc. ("NNRX USA" or "The Company"), a diversified nutraceutical company with operating segments in the sales of retail nutraceuticals and dietary supplements, nutraceutical OEM and formulations, and a distributor and researcher of medical foods, today reported the shipment of Nutranomics® AD Forte and private label formulations of Amazyme, and Pairzyme to Korea and Japan. Nutranomics' Northeast Asian distributors and retailers were awaiting restocking orders of the Company's products which were pending formulation and packaging.

"Restocking orders for our international distributors was first on our list to accomplish," began Dr. Joe Eyring, CEO and President of NNRX USA. "The most critical of our operational inefficiencies identified in my letter last month was the inability to ship order backlog. While there is still work to do in many areas, such corrections have liberated a series of orders at our manufacturer which our customers have long-awaited. The order included; AD Forte, Amazyme, and Pairzyme, each labeled and packaged in Korean and Japanese languages as required for each individual market. Fulfilling international distributor and retailer demand, particularly those with deeply-rooted nutraceutical cultures, is an ongoing strategy for our Company. Dr. Gibbs has made inroads into many international markets in which we hope to grow their sales in coming quarters."

The orders shipped by the Company totaled $70,208 and should be recorded in the Company's first fiscal quarter, which ended on October 31, 2015. NNRX's fiscal year is August 1 to July 31 of any given year. The Company's pending Annual Report on Form 10-K ("10-K") for its FY2015 and its filing with the SEC will be accompanied by a press release and provide shareholders further update on the Company's performance to date for its first quarter, 2016.

About Nutranomics Inc.

Nutranomics, Inc. (OTC PINK: NNRX) has been at the forefront of research and development of nutritional food products since its inception in 1995. In the first years of its operations, Nutranomics provided research and development of supplement formulations and nutraceuticals for domestic and international brands. After developing 100's of successful formulations and patents, Nutranomics developed its own brand of nutraceuticals in 1997, Nutranomics®, and began to market and sell its products directly to consumers and into retail outlets. Nutranomics and NNRX maintains distribution and customers worldwide.
More than just a health supplement manufacturer, Nutranomics supports the worldwide community of people aiming for a healthy lifestyle by making education a core business philosophy.

Forward-Looking Statements:

Safe Harbor: This press release contains forward-looking information within the meaning of section 27A of the Securities Act of 1933 and section 21E of the Securities Exchange Act of 1934 and is subject to the Safe Harbor created by those sections. This material contains statements about expected future events and/or financial results that are forward-looking in nature and subject to risks and uncertainties. Such forward-looking statements by definition involve risks, uncertainties and other factors, which may cause the actual results, performance or achievements of Nutranomics Inc., to be materially different from the statements made herein.